DK1054885T3 - Benzisoxasolderivater med D4-antagonistisk virkning - Google Patents
Benzisoxasolderivater med D4-antagonistisk virkningInfo
- Publication number
- DK1054885T3 DK1054885T3 DK99914450T DK99914450T DK1054885T3 DK 1054885 T3 DK1054885 T3 DK 1054885T3 DK 99914450 T DK99914450 T DK 99914450T DK 99914450 T DK99914450 T DK 99914450T DK 1054885 T3 DK1054885 T3 DK 1054885T3
- Authority
- DK
- Denmark
- Prior art keywords
- amino
- sulfonyl
- group
- dialkyl
- alkoxy
- Prior art date
Links
- 150000008316 benzisoxazoles Chemical class 0.000 title abstract 2
- 230000003042 antagnostic effect Effects 0.000 title 1
- -1 nitro, amino Chemical group 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000006296 sulfonyl amino group Chemical group [H]N(*)S(*)(=O)=O 0.000 abstract 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 102000003962 Dopamine D4 receptors Human genes 0.000 abstract 1
- 108090000357 Dopamine D4 receptors Proteins 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98200400 | 1998-02-09 | ||
| PCT/EP1999/000852 WO1999040067A2 (en) | 1998-02-09 | 1999-02-05 | Benzisoxazole derivatives having d4-antagonistic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1054885T3 true DK1054885T3 (da) | 2007-10-15 |
Family
ID=8233376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99914450T DK1054885T3 (da) | 1998-02-09 | 1999-02-05 | Benzisoxasolderivater med D4-antagonistisk virkning |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6335326B1 (da) |
| EP (1) | EP1054885B1 (da) |
| JP (1) | JP4627882B2 (da) |
| AT (1) | ATE367389T1 (da) |
| AU (1) | AU3327399A (da) |
| CA (1) | CA2320120C (da) |
| DE (1) | DE69936572T2 (da) |
| DK (1) | DK1054885T3 (da) |
| ES (1) | ES2291023T3 (da) |
| PT (1) | PT1054885E (da) |
| WO (1) | WO1999040067A2 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4627882B2 (ja) | 1998-02-09 | 2011-02-09 | デユフアー・インターナシヨナル・リサーチ・ベー・ブイ | D4−アンタゴニスト活性を有するベンズイソキサゾール誘導体 |
| PT1216249E (pt) * | 1999-09-14 | 2004-04-30 | Aventis Pharma Inc | Derivados de etilicos e propilicos insubstituidos de tienoisoxazol-fenoxi uteis como antagonistas d4 |
| DK1216250T3 (da) * | 1999-09-14 | 2004-02-23 | Aventis Pharma Inc | Thienoisoxazolyl- og thienylpyrazolyl-phenoxy- substituerede propylderivater som D4-antagonister |
| US7091199B1 (en) | 1999-09-14 | 2006-08-15 | Aventis Pharmaceuticals Inc. | Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists |
| US7253165B2 (en) | 1999-09-14 | 2007-08-07 | Aventis Pharmaceuticals Inc. | Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists |
| ATE247110T1 (de) * | 1999-09-14 | 2003-08-15 | Aventis Pharma Inc | Benzisoxazolyl-, pyridoisoxazolyl- und benzthienyl-phenoxy derivate als d4 antagonisten |
| US7125903B1 (en) | 1999-09-14 | 2006-10-24 | Aventis Pharmaceuticals Inc. | Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists |
| AU2002258506A1 (en) | 2001-03-12 | 2002-09-24 | The Mclean Hospital Corporation | Dopamine d4 receptor antagonists as treatment for attention deficit-hyperactivity disorder |
| US8816090B2 (en) * | 2005-02-25 | 2014-08-26 | Pfizer Inc. | Benzisoxazole derivatives |
| WO2009013212A2 (en) * | 2007-07-26 | 2009-01-29 | F. Hoffmann-La Roche Ag | Dual modulators of 5-ht2a and d3 receptors |
| US8877778B2 (en) | 2010-12-15 | 2014-11-04 | Hoffmann-La Roche Inc. | Benzofurane compounds |
| US8921397B2 (en) | 2011-05-04 | 2014-12-30 | Hoffmann-La Roche Inc. | Benzofurane-piperidine compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4352811A (en) * | 1981-11-12 | 1982-10-05 | Hoechst-Roussel Pharmaceuticals Inc. | 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles |
| CA2116117A1 (en) | 1991-08-22 | 1993-03-04 | Hiroyuki Sueoka | Benzisoxazole compound and use thereof |
| JPH0641125A (ja) * | 1992-03-26 | 1994-02-15 | Yoshitomi Pharmaceut Ind Ltd | ベンゾイソオキサゾール化合物およびその用途 |
| DK60593D0 (da) * | 1993-05-26 | 1993-05-26 | Novo Nordisk As | Kemiske forbindelser, deres fremstilling og anvendelse |
| FR2749304B1 (fr) * | 1996-06-04 | 1998-06-26 | Adir | Nouveaux derives du 3-(piperid-4-yl)1,2-benzisoxazole et du 3-(piperazin-4-yl)1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| JP4627882B2 (ja) * | 1998-02-09 | 2011-02-09 | デユフアー・インターナシヨナル・リサーチ・ベー・ブイ | D4−アンタゴニスト活性を有するベンズイソキサゾール誘導体 |
-
1999
- 1999-02-05 JP JP2000530498A patent/JP4627882B2/ja not_active Expired - Fee Related
- 1999-02-05 EP EP99914450A patent/EP1054885B1/en not_active Expired - Lifetime
- 1999-02-05 US US09/601,795 patent/US6335326B1/en not_active Expired - Lifetime
- 1999-02-05 WO PCT/EP1999/000852 patent/WO1999040067A2/en not_active Ceased
- 1999-02-05 AT AT99914450T patent/ATE367389T1/de active
- 1999-02-05 AU AU33273/99A patent/AU3327399A/en not_active Abandoned
- 1999-02-05 DE DE69936572T patent/DE69936572T2/de not_active Expired - Lifetime
- 1999-02-05 DK DK99914450T patent/DK1054885T3/da active
- 1999-02-05 PT PT99914450T patent/PT1054885E/pt unknown
- 1999-02-05 ES ES99914450T patent/ES2291023T3/es not_active Expired - Lifetime
- 1999-02-05 CA CA002320120A patent/CA2320120C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1054885B1 (en) | 2007-07-18 |
| US6335326B1 (en) | 2002-01-01 |
| EP1054885A2 (en) | 2000-11-29 |
| AU3327399A (en) | 1999-08-23 |
| CA2320120A1 (en) | 1999-08-12 |
| DE69936572T2 (de) | 2008-06-19 |
| ES2291023T3 (es) | 2008-02-16 |
| WO1999040067A3 (en) | 1999-11-25 |
| CA2320120C (en) | 2009-08-11 |
| DE69936572D1 (de) | 2007-08-30 |
| ATE367389T1 (de) | 2007-08-15 |
| JP4627882B2 (ja) | 2011-02-09 |
| PT1054885E (pt) | 2007-10-03 |
| JP2002502842A (ja) | 2002-01-29 |
| WO1999040067A2 (en) | 1999-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0858461T3 (da) | Kondenserede tropanderivater som neurotransmittergenoptagelsesinhibitorer | |
| DK1054885T3 (da) | Benzisoxasolderivater med D4-antagonistisk virkning | |
| UA72917C2 (en) | Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor | |
| MEP61208A (en) | Novel compounds having inhibitory activity against sodium-dependant transporter | |
| MX9709951A (es) | Derivados de benzamida y su uso como antagonistas de vasopresina. | |
| MY114679A (en) | Aroyl-piperidine derivatives | |
| NO20033385L (no) | Fuserte heterocykliske forbindelser | |
| TR199902724T2 (xx) | Dopamine D3 resept�rleri mod�lat�rleri olarak tetrahidroisokuinolin t�revleri. | |
| ATE175661T1 (de) | Benzamid-derivate als vasopressin-antagonisten | |
| ZA939068B (en) | Amine derivatives | |
| EA199901062A1 (ru) | Производные хинолин-4-карбоксамида как антагонисты рецепторов нк-2 и нк-3 | |
| NO964698D0 (no) | Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase | |
| NO305287B1 (no) | AMPA antagonister | |
| PE20060770A1 (es) | Derivados de n-[(4,5-difenil-3-alquil-2-tienil)metil]amina como antagonistas de los receptores cannabinoides cb1 | |
| HUP9700955A2 (hu) | Szubsztituált 2-naftoil-guanidin-származékok, előállításuk, valamint az e vegyületeket tartalmazó gyógyszerkészítmények | |
| PE20001384A1 (es) | Derivados de acetamida no peptidicos como antagonistas de receptor de nk1 | |
| CY1108837T1 (el) | ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5 | |
| DE69907636D1 (de) | 2-aminochinolinderivate mit d4-agonistischer wirkung | |
| DK0712406T3 (da) | Kondenserende indolderivater som 5-HT4-receptorantagonister | |
| NO954769L (no) | 3-(indol-3-yl)propensyrederivater som NMDA-antagonister | |
| ES2132748T3 (es) | Herbicidas de carbamato. | |
| AR014847A1 (es) | 4-amino-(etilamino)-oxindoles agonistas del autoreceptor de dopamina y una composicion farmaceutica que los comprende | |
| ES2161892T3 (es) | Derivados de indol como profarmacos de agonistas de los receptores afines a 5-ht1. |